Vaccination of Melanoma Patients with an Allogeneic, Genetically Modified Interleukin 2-Producing Melanoma Cell Line-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vaccination of Melanoma Patients with an Allogeneic, Genetically Modified Interleukin 2-Producing Melanoma Cell Line

Published:2000-03-20 Issue:5 Volume:11 Page:739-750
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Osanto S.,Schiphorst P.P.,Weijl N.I.,Dijkstra N.,Wees A. Van,Brouwenstein N.,Vaessen N.,Krieken J.H.J.M. Van,Hermans J.,Cleton F.J.,Schrier P.I.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/10430340050015635

Reference31 articles.

1. Interleukin-2-induced, melanoma-specific T cells recognize camel, an unexpected translation product ofLAGE-1

2. Phenotypic Analysis of Antigen-Specific T Lymphocytes

3. Limited Antitumor T Cell Response in Melanoma Patients Vaccinated with Interleukin-2 Gene-Transduced Allogeneic Melanoma Cells

4. Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Cancer Vaccine Research;ACS Biomaterials Science & Engineering;2023-11-03

2. Immunological and functional aspects of MAGEA3 cancer/testis antigen;Advances in Protein Chemistry and Structural Biology;2021

3. Genetically engineered mesenchymal stem cells: targeted delivery of immunomodulatory agents for tumor eradication;Cancer Gene Therapy;2020-05-18

4. Therapeutic effects of iNOS inhibition against vitiligo in an animal model;European Journal of Translational Myology;2019-08-06

5. Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer;Clinical Cancer Research;2015-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3